LV12889B - Kristālisks ceftiofūrs brīvas skābes formā - Google Patents

Kristālisks ceftiofūrs brīvas skābes formā Download PDF

Info

Publication number
LV12889B
LV12889B LVP-02-107A LV020107A LV12889B LV 12889 B LV12889 B LV 12889B LV 020107 A LV020107 A LV 020107A LV 12889 B LV12889 B LV 12889B
Authority
LV
Latvia
Prior art keywords
crystalline
free acid
ceftiofur
oil
compound
Prior art date
Application number
LVP-02-107A
Other languages
English (en)
Latvian (lv)
Inventor
Michael J. Dunn
Michael S. Bergren
Gregory E. Hardee
Kenneth Paul Shephard
Robert S. Chao
Jeffrey L. Havens
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of LV12889B publication Critical patent/LV12889B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LVP-02-107A 1993-03-12 2002-06-13 Kristālisks ceftiofūrs brīvas skābes formā LV12889B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3329193A 1993-03-12 1993-03-12

Publications (1)

Publication Number Publication Date
LV12889B true LV12889B (lv) 2002-12-20

Family

ID=21869579

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-02-107A LV12889B (lv) 1993-03-12 2002-06-13 Kristālisks ceftiofūrs brīvas skābes formā

Country Status (31)

Country Link
US (1) US5721359A (hr)
EP (1) EP0690864B1 (hr)
JP (1) JP3852946B2 (hr)
KR (1) KR100296810B1 (hr)
CN (1) CN1055090C (hr)
AT (1) ATE202109T1 (hr)
AU (1) AU694419B2 (hr)
BR (1) BR1101034A (hr)
CA (1) CA2155322C (hr)
CZ (1) CZ289332B6 (hr)
DE (2) DE69427469T2 (hr)
DK (1) DK0690864T3 (hr)
ES (1) ES2157254T3 (hr)
FI (1) FI120307B (hr)
FR (1) FR05C0045I2 (hr)
GR (1) GR3036514T3 (hr)
HU (1) HU222244B1 (hr)
IL (1) IL108910A (hr)
LU (1) LU91206I2 (hr)
LV (1) LV12889B (hr)
NL (1) NL300208I2 (hr)
NO (2) NO313199B1 (hr)
NZ (1) NZ263002A (hr)
PL (1) PL184611B1 (hr)
PT (1) PT690864E (hr)
RU (1) RU2136685C1 (hr)
SI (1) SI0690864T1 (hr)
SK (1) SK283674B6 (hr)
TW (1) TW267170B (hr)
WO (1) WO1994020505A1 (hr)
ZA (1) ZA941586B (hr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
PT1317256E (pt) * 2000-09-12 2008-12-17 Pharmacia & Upjohn Co Llc Composição farmacêutica com veículo modificado
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
WO2003006441A1 (en) * 2001-07-10 2003-01-23 Pharmacia & Upjohn Company Crystalline thiazine oxazolidinones
CA2455050C (en) * 2001-08-15 2007-02-20 Pharmacia & Upjohn Company Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
BR0308523A (pt) † 2002-03-21 2005-02-01 Upjohn Co Método de administração de um antibiótico injetável à orelha de um animal
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US20040115822A1 (en) * 2002-09-12 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US20040115837A1 (en) * 2002-11-27 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
EP1606293B1 (en) * 2003-03-27 2009-08-19 Basilea Pharmaceutica AG Cephalosporin in crystalline form
EP1728791A4 (en) 2004-03-25 2008-12-10 Astellas Pharma Inc COMPOSITIONS FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR BZW. A SALT OF IT
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
US8470809B2 (en) * 2005-10-12 2013-06-25 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
BRPI0617561A2 (pt) * 2005-10-12 2011-08-23 Orchid Chemicals & Pharm Ltd sal de sódio cristalino antibiótico de cefalosporina
TW201446748A (zh) 2007-08-22 2014-12-16 Astrazeneca Ab 環丙基醯胺衍生物
WO2010036427A1 (en) 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
EP2324034A4 (en) * 2008-08-22 2012-05-16 Orchid Chemicals & Pharm Ltd CRYSTALLINE SODIUM SALT OF CEPHALOSPORIN ANTIBIOTIC
BRPI0922041A8 (pt) * 2008-11-19 2022-08-16 Merial Ltd Formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico.
EP4242206A1 (en) * 2009-01-30 2023-09-13 Novartis AG Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
EP2536702A4 (en) * 2010-02-18 2013-07-10 Astrazeneca Ab NEW CRYSTALLINE FORM OF A CYCLOPROPYLBENZAMIDE DERIVATIVE
EP2536701A4 (en) * 2010-02-18 2014-05-07 Astrazeneca Ab SOLID FORMS WITH A CYCLOPROPYLAMID DERIVATIVE
CN103649097A (zh) * 2011-05-02 2014-03-19 佐蒂斯有限责任公司 用作抗菌剂的新型头孢菌素类
CN104039369B (zh) 2011-07-20 2017-06-16 布莱阿姆青年大学 疏水性塞拉集宁化合物和包含该化合物的装置
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
BR112014005914B1 (pt) 2011-09-13 2021-11-09 Brigham Young University Produtos para cicatrização de feridas tecidulares
EP2755661A1 (en) 2011-09-13 2014-07-23 Brigham Young University Compositions for treating bone diseases and broken bones
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
KR20140116111A (ko) 2011-12-21 2014-10-01 브라이엄 영 유니버시티 구강 관리 조성물
CN102584855B (zh) * 2012-02-16 2014-06-25 青岛科技大学 一种改进的头孢噻呋的制备方法
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
CA2872399C (en) 2012-05-02 2021-01-12 Brigham Young University Ceragenin particulate materials and methods for making same
CA2888259C (en) 2012-10-17 2019-05-28 Brigham Young University Treatment and prevention of mastitis
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
CN105451742B (zh) 2013-01-07 2021-04-06 布莱阿姆青年大学 减少细胞增殖和治疗某些疾病的方法
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
JP6518230B2 (ja) 2013-03-15 2019-05-22 ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ 炎症、自己免疫疾患、および疼痛を治療する方法
RU2546675C2 (ru) * 2013-04-11 2015-04-10 Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП") Способ определения степени кристалличности составов на основе дифениламина
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US9643920B2 (en) * 2013-09-05 2017-05-09 Mitsubishi Tanabe Pharma Corporation Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
AU2015335950B2 (en) * 2014-10-21 2018-01-25 Takeda Pharmaceutical Company Limited Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl}pyrimidine-2,4-diamine
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
KR101753842B1 (ko) * 2015-05-12 2017-07-04 한국화학연구원 불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
CN106543203B (zh) * 2015-09-18 2019-07-02 瑞普（天津）生物药业有限公司 一种长效头孢噻呋自由酸晶体的制备方法
CN108495844B (zh) * 2016-01-22 2022-12-02 桑多斯股份公司 结晶埃拉环素二盐酸盐
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
KR101898282B1 (ko) * 2016-05-24 2018-09-13 주식회사 고려비엔피 항생제의 서방형 수의학적 조성물 및 이의 제조방법
KR20230074840A (ko) * 2016-07-07 2023-05-31 사이클리온 테라퓨틱스, 인크. sGC 자극제의 고체 형태
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
TW202233625A (zh) * 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1207933B (de) * 1962-12-26 1965-12-30 American Home Prod Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin
US3489750A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
EP0233255B1 (en) * 1985-08-12 1996-05-29 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
GB8608962D0 (en) * 1986-04-12 1986-05-14 Beecham Group Plc Beta-lactam antibiotics
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.
ES2032543T3 (es) * 1987-02-02 1993-02-16 Eli Lilly And Company Procedimiento mejorado de preparacion de un antibiotico.
EP0386000B1 (en) * 1987-07-29 1992-03-11 The Upjohn Company Controlled release of antibiotic salts from an implant
EP0393066B1 (en) * 1987-11-10 1994-02-02 The Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes

Also Published As

Publication number Publication date
HUT73781A (en) 1996-09-30
SK111495A3 (en) 1995-12-06
DE69427469D1 (en) 2001-07-19
NO2005025I1 (no) 2005-12-05
JP3852946B2 (ja) 2006-12-06
DE122005000055I1 (de) 2006-02-23
NL300208I2 (nl) 2006-05-01
WO1994020505A1 (en) 1994-09-15
RU2136685C1 (ru) 1999-09-10
NZ263002A (en) 1996-12-20
NL300208I1 (nl) 2006-02-01
NO313199B1 (no) 2002-08-26
TW267170B (hr) 1996-01-01
FI954250A0 (fi) 1995-09-11
FI120307B (fi) 2009-09-15
FR05C0045I2 (hr) 2007-08-03
BR1101034A (pt) 2002-04-30
CN1055090C (zh) 2000-08-02
IL108910A0 (en) 1994-06-24
EP0690864B1 (en) 2001-06-13
PL184611B1 (pl) 2002-11-29
NO2005025I2 (no) 2010-11-22
US5721359A (en) 1998-02-24
DE69427469T2 (de) 2001-10-31
ATE202109T1 (de) 2001-06-15
PT690864E (pt) 2001-11-30
DE122005000055I2 (de) 2008-06-05
PL310556A1 (en) 1995-12-27
SI0690864T1 (en) 2001-10-31
HU9501960D0 (en) 1995-09-28
DK0690864T3 (da) 2001-09-17
CZ9502290A3 (cs) 2001-08-15
CN1119016A (zh) 1996-03-20
FI954250A (fi) 1995-09-11
GR3036514T3 (en) 2001-12-31
AU6351094A (en) 1994-09-26
SK283674B6 (sk) 2003-11-04
CA2155322C (en) 2000-02-29
NO953564L (no) 1995-11-07
FR05C0045I1 (hr) 2006-01-06
HU222244B1 (hu) 2003-05-28
CA2155322A1 (en) 1994-09-15
ZA941586B (en) 1995-09-07
ES2157254T3 (es) 2001-08-16
JPH08507519A (ja) 1996-08-13
NO953564D0 (no) 1995-09-11
EP0690864A1 (en) 1996-01-10
LU91206I2 (fr) 2006-05-30
KR100296810B1 (ko) 2001-10-24
AU694419B2 (en) 1998-07-23
CZ289332B6 (cs) 2002-01-16
IL108910A (en) 1999-10-28

Similar Documents

Publication Publication Date Title
EP0690864B1 (en) Crystalline ceftiofur free acid
KR0180798B1 (ko) 결정성 페니실린 유도체, 그의 제법 및 용도
PL172830B1 (pl) Preparat farmaceutyczny do zwalczania bakterii PL PL PL PL PL
TW200944508A (en) Novel solid forms of bendamustine hydrochloride
JP3726291B2 (ja) 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPS6145626B2 (hr)
EP0189942B1 (en) Cefbuperazone crystalline triethylamine salt
CN112094249A (zh) 磺胺甲噻二唑-糖精共晶及其制备方法与应用
FI62311B (fi) Foerfarande foer framstaellning av kristallint natrium- och kaiumcefalexinmonohydrat
AU712904B2 (en) Improved process for preparing potassium clavulanate
BG65240B1 (bg) Кристална полиморфна форма на азабицикло (2,2,2) октан-3-амин цитрат и фармацевтичен състав, който я съдържа, метод за получаване и използването
US4791196A (en) Crystalline cephem carboxylic acid addition salt
JPH0692970A (ja) トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
KR20070007766A (ko) 3-베타-아미노 17-메틸렌 안드로스테인-6-알파 7-베타-디올하이드로클로라이드의 결정질 형태
MXPA05010083A (es) Cefalosporina en forma cristalina.
JPWO2004039816A1 (ja) セフェム化合物の無機酸塩の結晶
CS195747B2 (cs) Způsob výroby krystalické bezvodé sodné soli cefamandolu
KR20100082582A (ko) 세프디니르 고체분산체 및 이를 제조하는 방법